Bevacizumab induces ferroptosis and enhances CD8+ T cell immune activity in liver cancer via modulating HAT1 and increasing IL-9
Chunyu Hou, Pan Lv, Hong-Feng Yuan, Lina Zhao, Yufei Wang, Huihui Zhang, Guang Yang, Xiaodong Zhang
Topics & Concepts
BevacizumabImmune systemLiver cancerCancer researchCD8Cytotoxic T cellBiologyMedicinePharmacologyImmunologyInternal medicineBiochemistryChemotherapyHepatocellular carcinomaIn vitroFerroptosis and cancer prognosisRNA modifications and cancerCancer Immunotherapy and Biomarkers